NASDAQ: TNYA
Tenaya Therapeutics Inc Stock Ownership - Who owns Tenaya Therapeutics?

Insider buying vs selling

Have Tenaya Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Faraz AliCEO2026-08-177,406$0.71
$5.26kSell
Whittemore TingleyMed2026-08-171,637$0.71
$1.16kSell
Whittemore TingleyMed2026-08-171,871$0.71
$1.33kSell
Whittemore TingleyMed2026-08-171,637$0.71
$1.16kSell
Whittemore TingleyMed2026-08-172,279$0.71
$1.62kSell
Faraz AliCEO2026-08-175,837$0.71
$4.14kSell
Faraz AliCEO2026-08-173,969$0.71
$2.82kSell
Faraz AliCEO2026-08-175,020$0.71
$3.56kSell
Whittemore TingleyChief Medical Officer2026-05-183,121$0.79
$2.48kSell
Faraz AliChief Executive Officer2026-05-183,390$0.79
$2.69kSell

1 of 4

TNYA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TNYA insiders and whales buy or sell their stock.

TNYA Shareholders

What type of owners hold Tenaya Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Column Group III GP LP26.39%59,183,833$21.31MInsider
David V. Goeddel6.63%14,855,844$5.35MInsider
Eli Casdin2.87%6,440,829$2.32MInsider
Deepak Srivastava0.31%705,767$254.08kInsider
Faraz Ali0.24%539,782$194.32kInsider
Casdin Partners Master Fund LP0.16%361,969$130.31kInsider
Whittemore Tingley0.12%263,073$94.71kInsider
Timothy Hoey0.11%245,346$88.32kInsider
Tomohiro Higa0.05%118,267$42.58kInsider
Leone D. Patterson0.04%95,755$34.47kInsider

1 of 3

TNYA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TNYA0.02%37.00%Net SellingNet Selling
NTHI0.01%99.99%Net BuyingNet Buying
ATRA0.03%99.97%Net BuyingNet Buying
CLLS0.01%0.00%
RLYB0.01%99.99%Net BuyingNet Buying

Tenaya Therapeutics Stock Ownership FAQ

Who owns Tenaya Therapeutics?

Tenaya Therapeutics (NASDAQ: TNYA) is owned by 0.02% institutional shareholders, 37.00% Tenaya Therapeutics insiders, and 62.98% retail investors. Column Group III GP LP is the largest individual Tenaya Therapeutics shareholder, owning 59.18M shares representing 26.39% of the company. Column Group III GP LP's Tenaya Therapeutics shares are currently valued at $21.90M.

If you're new to stock investing, here's how to buy Tenaya Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.